<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">22167583</PMID>
        <DateCompleted>
            <Year>2013</Year>
            <Month>02</Month>
            <Day>12</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1860-2002</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>14</Volume>
                    <Issue>5</Issue>
                    <PubDate>
                        <Year>2012</Year>
                        <Month>Oct</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging</Title>
                <ISOAbbreviation>Mol Imaging Biol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Half-time SPECT acquisition with resolution recovery for Tc-MIBI SPECT imaging in the assessment of hyperparathyroidism.</ArticleTitle>
            <Pagination>
                <MedlinePgn>647-51</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11307-011-0530-2</ELocationID>
            <Abstract>
                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Reduced SPECT acquisition time protocols have been recently developed based on collimator-detector response compensation reconstruction. The present study aims to evaluate the potential use of a short-time technetium-99m methoxyisobutylisonitrile (Tc99m-MIBI) SPECT algorithm in the investigation of parathyroid adenoma (PTA).</AbstractText>
                <AbstractText Label="PROCEDURES" NlmCategory="METHODS">Ninety patients (59 women; age range, 21-76 years) with biochemical evidence of hyperparathyroidism were referred for Tc99m-MIBI scintigraphy for diagnosis and localization of PTA. Standard full-time and half-time SPECT studies starting at 45 min after injection were performed in random order in all patients. PTA detection rate and overall image quality parameters were evaluated and graded for each study and compared for the two SPECT protocols.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Focal (99m)Tc-sestamibi uptake consistent with PTA was reported in 60 out of 90 studies (67%). Congruent results between the full- and half-time SPECT acquisition were found in 73 patients (81%). Minor disagreement between the two SPECT protocols with respect to PTA detectability was found in 17 patients but with no statistically significant difference (p = 0.67). The correlation coefficient between the two SPECTs was r = 0.88 (p &lt; 0.0001), and the Bland-Altman correlation analysis confirmed the interchangeability of the two protocols. Image quality was reported as either good or excellent for all studies, and no statistical significant difference in image quality scoring between protocols was found (p = 0.155).</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Parathyroid MIBI SPECT can be performed using the collimator-detector response compensation reconstruction algorithm for only half of the scanning time without compromising significant diagnostic data.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Bar</LastName>
                    <ForeName>Ronen</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otolaryngology, Head and Neck Surgery, Rambam Health Care Campus, Haifa, Israel.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Przewloka</LastName>
                    <ForeName>Kinga</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Karry</LastName>
                    <ForeName>Rachel</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Frenkel</LastName>
                    <ForeName>Alex</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Golz</LastName>
                    <ForeName>Avishay</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Keidar</LastName>
                    <ForeName>Zohar</ForeName>
                    <Initials>Z</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Mol Imaging Biol</MedlineTA>
            <NlmUniqueID>101125610</NlmUniqueID>
            <ISSNLinking>1536-1632</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>971Z4W1S09</RegistryNumber>
                <NameOfSubstance UI="D017256">Technetium Tc 99m Sestamibi</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006961" MajorTopicYN="N">Hyperparathyroidism</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010282" MajorTopicYN="N">Parathyroid Neoplasms</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017256" MajorTopicYN="Y">Technetium Tc 99m Sestamibi</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015899" MajorTopicYN="N">Tomography, Emission-Computed, Single-Photon</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2011</Year>
                <Month>12</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2011</Year>
                <Month>12</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2013</Year>
                <Month>2</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">22167583</ArticleId>
            <ArticleId IdType="doi">10.1007/s11307-011-0530-2</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Nucl Med. 2007 Jul;48(7):1084-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17574983</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Nucl Med Mol Imaging. 2006 Sep;33(9):1091-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16804688</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Nucl Med. 2009 Apr;50(4):554-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19289436</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Nucl Med. 2005 Oct;35(4):266-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16150247</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Otolaryngol. 2009;2009:739798</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20169134</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Nucl Med Mol Imaging. 2010 Apr;37(4):750-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19921186</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucl Med Commun. 2010 Mar;31(3):217-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20032802</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Surg Endosc. 2003 May;17 (5):688-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12618931</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Bone Miner Res. 1991 Oct;6 Suppl 2:S1-166</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1763659</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Nucl Cardiol. 2009 Sep-Oct;16(5):714-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19582531</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Nucl Med. 2008 Feb;22(2):123-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18311537</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>